Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Comment by dimar66on Sep 28, 2008 1:10am
316 Views
Post# 15489366

RE: No demand for Flu Tests

RE: No demand for Flu TestsWyeth what is your point?
You said:

SO,

Roche, our esteemed partner  for cardiac, chose Quidel's test for flu A+B .

So 3M nabbed the Ramp test and locked it in an exclusive deal before competitors could, 3M wants the best tests for its infectious disease program. From the Response webpage:
The test will be marketed and sold exclusively by 3M as the 3M Rapid Detection Influenza A+B test.


So here we are are waiting to hear about the financing and news to verify sales; so we have nothing better to do than play games with the devil.  So uncertainty and bad market conditions have driven the share price down, but there is no indication that the prospects of the company have changed at all.  I am holding long and if need be longer.

dimar

Bullboard Posts